Risk-treatment mismatch in the pharmacotherapy of heart failure
Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, Chong A, Stukel TA, Levy D, Laupacis A. JAMA. 2005; 294(10):1240-7.
Publications
Uptake and Outcomes Associated with Cyclooxgenase (COX-2) Inhibitors in Ontario’s Elderly
Identifying individuals with reduced GFR using ambulatory laboratory database surveillance
Garg AX, Mamdani M, Juurlink DN, van Walraven C; Network of Eastern Ontario Medical Laboratories (NEO-MeL). J Am Soc Nephrol. 2005; 16(5):1433-9. Epub 2005 Mar 30.
Hyperbaric oxygen for carbon monoxide poisoning
Juurlink DN, Buckley NA, Stanbrook MB, Isbister GK, Bennett M, McGuigan MA. Cochrane Database Syst Rev. 2005; (1):CD002041.
Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors
Battistella M, Mamdani MM, Juurlink DN, Rabeneck L, Laupacis A. Arch Intern Med. 2005; 165(2):189-92.
A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin
Juurlink DN, Mamdani MM, Kopp A, Herrmann N, Laupacis A. Br J Clin Pharmacol. 2005; 59(1):102-7. Epub 2004 Dec 16.
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. N Engl J Med. 2004; 351(6):543-51.
Medical illness and the risk of suicide in the elderly
Juurlink DN, Herrmann N, Szalai JP, Kopp A, Redelmeier DA. Arch Intern Med. 2004; 164(11):1179-84.
Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study
Mamdani M, Juurlink DN, Lee DS, Rochon PA, Kopp A, Naglie G, Austin PC, Laupacis A, Stukel TA. Lancet. 2004; 363(9423):1751-6.
Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study
Mamdani M, Juurlink DN, Kopp A, Naglie G, Austin PC, Laupacis A. BMJ. 2004; 328(7453):1415-6. Epub 2004 May 11.